Agios Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
27.80
-0.24
(-0.86%)
Volume:
99,717
52 week range:
23.42 - 62.58
Market Cap:
1.624B
Company Description:
Agios Pharmaceuticals, Inc. engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes. AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications.